NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212 | +146.5% | 29,228 | +135.1% | 0.00% | – |
| Q1 2023 | $86 | -100.0% | 12,432 | +20.8% | 0.00% | -100.0% |
| Q3 2022 | $187,000 | -80.6% | 10,294 | -45.0% | 0.00% | -80.0% |
| Q2 2022 | $962,000 | -9.6% | 18,713 | +29.6% | 0.01% | 0.0% |
| Q1 2022 | $1,064,000 | -37.2% | 14,441 | +22.1% | 0.01% | -37.5% |
| Q4 2021 | $1,693,000 | -4.1% | 11,832 | +38.9% | 0.01% | -11.1% |
| Q3 2021 | $1,766,000 | +5.2% | 8,519 | +7.8% | 0.01% | +12.5% |
| Q2 2021 | $1,678,000 | +52.7% | 7,906 | +30.4% | 0.01% | +33.3% |
| Q1 2021 | $1,099,000 | +5.3% | 6,061 | -35.3% | 0.01% | 0.0% |
| Q4 2020 | $1,044,000 | -6.9% | 9,366 | -9.5% | 0.01% | -25.0% |
| Q3 2020 | $1,121,000 | +77.4% | 10,346 | +36.5% | 0.01% | +60.0% |
| Q2 2020 | $632,000 | – | 7,580 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |